Bernard Waeber
#163,909
Most Influential Person Across History
Bernard Waeber's AcademicInfluence.com Rankings
Download Badge
Medical Philosophy
Bernard Waeber's Degrees
- Doctorate Medicine University of Geneva
- PhD Cardiology University of Geneva
Why Is Bernard Waeber Influential?
(Suggest an Edit or Addition)Bernard Waeber's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
- 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (5476)
- 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
- 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension (2003) (2640)
- European Society of Hypertension position paper on ambulatory blood pressure monitoring. (2013) (1184)
- 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. (2013) (1115)
- The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) (2013) (991)
- European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring (2008) (823)
- The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
- Blood pressure measuring devices: recommendations of the European Society of Hypertension (2001) (758)
- 2013 ESH/ESC Guidelines for the management of arterial hypertension (2013) (754)
- European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. (2014) (731)
- Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults (2002) (721)
- 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension (2014) (579)
- Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. (2002) (474)
- European Society of Hypertension Practice Guidelines for home blood pressure monitoring (2010) (465)
- Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. (1979) (374)
- Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. (2003) (368)
- Antihypertensive Therapy with MK 4211: Angiotensin II‐Renin Relationships to Evaluate Efficacy of Converting Enzyme Blockade (1982) (261)
- Oral Administration of DuP 753, a Specific Angiotensin II Receptor Antagonist, to Normal Male Volunteers: Inhibition of Pressor Response to Exogenous Angiotensin I and II (1991) (253)
- Determinants of angiotensin II generation during converting enzyme inhibition. (1990) (232)
- Hypertension: a disease of the microcirculation? (2006) (225)
- Conduit artery compliance and distensibility are not necessarily reduced in hypertension. (1992) (213)
- Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. (1993) (199)
- Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist (1992) (191)
- True Versus Immunoreactive Angiotensin II in Human Plasma (1985) (191)
- Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. (2000) (191)
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421". (1981) (190)
- Hypertension and microvascular remodelling. (2008) (173)
- Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition (1990) (173)
- IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRIL (1979) (172)
- Isolated office hypertension: a prehypertensive state? (1996) (159)
- Isobaric compliance of the radial artery is increased in patients with essential hypertension (1993) (150)
- Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers (1987) (146)
- Is nitric oxide overproduction the target of choice for the management of septic shock? (2001) (146)
- Discrepancy Between Antihypertensive Effect and Angiotensin Converting Enzyme Inhibition by Captopril (1980) (139)
- Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. (2006) (137)
- Compliance with antihypertensive therapy. (1999) (135)
- Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. (1986) (134)
- Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? (2003) (133)
- Knowledge, attitudes, and practices on hypertension in a country in epidemiological transition. (1998) (130)
- Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. (1985) (126)
- The role of neuropeptide Y in cardiovascular regulation. (1991) (125)
- Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. (2001) (121)
- Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. (1990) (120)
- Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach (2004) (115)
- The macrocirculation and microcirculation of hypertension (2009) (114)
- Monitoring one-year compliance to antihypertension medication in the Seychelles. (2002) (107)
- The past, present and future of renin-angiotensin aldosterone system inhibition. (2013) (106)
- Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. (1999) (105)
- Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. (1995) (104)
- Hypertension increases connexin43 in a tissue-specific manner. (1997) (101)
- Cutting Edge: IL-1α Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial Infarction (2015) (100)
- Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. (1995) (96)
- Skin blood flow reduction induced by cigarette smoking: role of vasopressin. (1984) (95)
- Ambulatory blood pressure recordings. Reproducibility and unpredictability. (1984) (93)
- Pharmacokinetics of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers and the Relationship to Enzyme Inhibition: Development of a Mathematical Model (1987) (92)
- Effect of atriopeptin III on hematocrit and volemia of nephrectomized rats. (1986) (91)
- [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
- Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. (1985) (90)
- Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection (2005) (86)
- Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. (1999) (86)
- Four‐Hour Infusions of Synthetic Atrial Natriuretic Peptide in Normal Volunteers (1986) (85)
- Electronic Monitoring of Compliance to Lipid‐Lowering Therapy in Clinical Practice (1999) (81)
- Peroxynitrite Is a Potent Inhibitor of NF-κB Activation Triggered by Inflammatory Stimuli in Cardiac and Endothelial Cell Lines* (2005) (80)
- Caffeine‐Induced Diuresis and Atrial Natriuretic Peptides (1990) (79)
- Blunted vasodilatory responses in the cutaneous microcirculation of cigarette smokers. (2001) (78)
- A Disease of the Microcirculation ? (2006) (73)
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILURE (1978) (73)
- Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes. (2005) (73)
- Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension (2009) (73)
- Clinical Use of an Orally Acting Converting Enzyme Inhibitor: Captopril (1980) (72)
- Lithium Infusion to Study Sodium Handling in Unanesthetized Hypertensive Rats (1986) (71)
- Spontaneous diameter oscillations of the radial artery in humans. (1993) (71)
- Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers. (1986) (71)
- ARE SOME HYPERTENSIVE PATIENTS OVERTREATED? A Prospective Study of Ambulatory Blood Pressure Recording (1987) (70)
- Oxidants Positively or Negatively Regulate Nuclear Factor κB in a Context-dependent Manner* (2010) (70)
- Individual responses to converting enzyme inhibitors and calcium antagonists. (1988) (69)
- Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension (2003) (68)
- Effect of captopril on renal vascular tone in patients with essential hypertension. (1979) (67)
- Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. (2011) (66)
- Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension (1995) (62)
- How to improve adherence with prescribed treatment in hypertensive patients? (2000) (62)
- The present molecules of converting enzyme inhibitors. (1985) (62)
- Production and characterization of four anti-neuropeptide Y monoclonal antibodies. (1992) (61)
- Evaluation of Arterial Compliance‐Pressure Curves Effect of Antihypertensive Drugs (1991) (60)
- Postischemic blood flow response in hypercholesterolemic patients. (1995) (59)
- A novel cyclic analog of neuropeptide Y specific for the Y2 receptor. (1992) (58)
- Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion (2006) (57)
- Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods. (1984) (56)
- Task Force IV: Clinical use of ambulatory blood pressure monitoring (1999) (55)
- In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II. (1988) (55)
- Cardiovascular effects of neuropeptide Y. (1988) (54)
- Site of the action of a synthetic atrial natriuretic peptide evaluated in humans. (1987) (53)
- Angiotensin-II receptor blockers: benefits beyond blood pressure reduction? (2005) (52)
- Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. (1994) (52)
- Dose-response relationships following oral administration of DuP 753 to normal humans. (1991) (52)
- IMPROVED BLOOD PRESSURE CONTROL BY MONITORING COMPLIANCE WITH ANTIHYPERTENSIVE THERAPY (1999) (52)
- Hemodynamic and Humoral Effects of the New Renin Inhibitor Enalkiren in Normal Humans (1989) (52)
- Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects (1986) (50)
- Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems. (1995) (50)
- Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans. (1989) (49)
- Endothelin-1 does not mediate the endothelium-dependent hypoxic contractions of small pulmonary arteries in rats. (1996) (48)
- Effect of weight reduction in moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium. (1991) (48)
- Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice (2010) (48)
- Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes (2008) (47)
- Discrepancies between office and ambulatory blood pressure: clinical implications. (2009) (47)
- Clinical pharmacology of the angiotensin II receptor antagonist losartan potassium in healthy subjects (1995) (47)
- Endurance training enhances vasodilation induced by nitric oxide in human skin. (2003) (46)
- Microalbuminuria breakthrough under chronic renin–angiotensin–aldosterone system suppression (2012) (45)
- Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone (2001) (43)
- Self-measurement of blood pressure in clinical trials and therapeutic applications. (2000) (43)
- Cardiovascular hypertrophy: role of angiotensin II and bradykinin. (1996) (43)
- Hemodynamic and Biochemical Consequences of Renin Inhibition by Infusion of CGP 38560A in Normal Volunteers (1989) (42)
- Homocysteine induces cell death in H9C2 cardiomyocytes through the generation of peroxynitrite. (2007) (41)
- Local heating of human skin causes hyperemia without mediation by muscarinic cholinergic receptors or prostanoids. (2004) (41)
- Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications. (2005) (41)
- ACUTE INFLAMMATION DECREASES THE EXPRESSION OF CONNEXIN 40 IN MOUSE LUNG (2007) (41)
- Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. (2010) (41)
- Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia. (1995) (41)
- Effect of the Renin Response During Renin Inhibition: Oral Ro 42–5892 in Normal Humans (1991) (40)
- Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system. (1993) (40)
- Treatment Strategy to Control Blood Pressure Optimally in Hypertensive Patients (2001) (40)
- Dose-Dependent Vasodilatory Effects of Acetylcholine and Local Warming on Skin Microcirculation (2004) (39)
- The advantages of angiotensin II antagonism. (1994) (39)
- Task force VI: Self-monitoring of the blood pressure. (1999) (39)
- A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y (1992) (38)
- Endothelium-Dependent Vasodilation in the Skin Microcirculation of Patients with Septic Shock (2003) (38)
- Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A. (1987) (38)
- Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats. (1995) (38)
- Evaluation of an online, case-based interactive approach to teaching pathophysiology (2008) (37)
- Angiotensin Converting Enzyme Inhibition: Discrepancy Between Antihypertensive Effect and Suppression of Enzyme Activity (1989) (37)
- Global cardiovascular protection in chronic kidney disease (2016) (37)
- Clinical experience with angiotensin II receptor antagonists. (1992) (37)
- Ambulatory blood pressure recording to identify hypertensive patients who truly need therapy. (1984) (37)
- Does vasopressin sustain blood pressure of normally hydrated healthy volunteers? (1984) (36)
- Bacterial Flagellin Triggers Cardiac Innate Immune Responses and Acute Contractile Dysfunction (2010) (36)
- A comparative study of reactive hyperemia in human forearm skin and muscle. (2008) (36)
- Therapeutic strategies to improve control of hypertension (2013) (36)
- Endotheliai function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia (1995) (36)
- The Opposing Effects of Chronic Angiotensin‐Converting Enzyme Blockade by Captopril on the Responses to Exogenous Angiotensin II and Vasopressin vs. Norepinephrine in Rats (1981) (36)
- Acetylcholine‐Induced Vasodilation and Reactive Hyperemia Are Not Affected by Acute Cyclo‐Oxygenase Inhibition in Human Skin (2004) (36)
- Beta‐blockade with nebivolol enhances the acetylcholine‐induced cutaneous vasodilation (2001) (35)
- Combination antihypertensive therapy: does it have a role in rational therapy? (1997) (35)
- Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line. (1993) (35)
- Effects of angiotensin converting enzyme inhibition: a clinical point of view. (1985) (34)
- Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents. (1988) (34)
- The return of increased blood pressure after discontinuation of antihypertensive treatment is associated with an impaired post-ischemic skin blood flow response (2001) (34)
- Acute Endotoxemia Inhibits Microvascular Nitric Oxide-Dependent Vasodilation in Humans (2011) (34)
- Clinical and hemodynamic correlates of elevated plasma arginine vasopressin after acute myocardial infarction. (1987) (34)
- Hypertension differentially affects the expression of the gap junction protein connexin43 in cardiac myocytes and aortic smooth muscle cells. (1997) (34)
- The Vasodilatory Response of Skin Microcirculation to Local Heating is Subject to Desensitization (2009) (34)
- Main objectives and new aspects of combination treatment of hypertension (1995) (33)
- Effects of Single Doses of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers (1987) (33)
- Systematic difference between blood pressure readings caused by cuff type. (1994) (32)
- Unpredictability of Blood Pressures Recorded Outside the Clinic in the Treated Hypertensive Patient (1986) (32)
- Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy (2012) (32)
- The multifactorial nature of hypertension: the greatest challenge for its treatment? (2001) (32)
- Prevention of renal hypertension in the rat by neuropeptide Y. (1990) (32)
- Blood pressure response to antihypertensive therapy: ambulatory versus office blood pressure readings. (1985) (31)
- Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitro. (1995) (31)
- Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity. (1982) (31)
- Whole-body vibration training elevates creatine kinase levels in sedentary subjects. (2011) (31)
- Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values. (1985) (31)
- Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey (2005) (31)
- Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects (1996) (30)
- High mobility group box 1 protein (HMGB-1): a pathogenic role in preeclampsia? (2014) (30)
- Use of drugs with more than a twenty‐four-hour duration of action (1994) (30)
- Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients. (2002) (30)
- Safety and Efficacy of Chronic Therapy with Captopril in Hypertensive Patients: An Update (1981) (30)
- Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension (1992) (29)
- Conclusions on the measurement of arterial wall thickness: anatomic, physiologic and methodologic considerations (1992) (29)
- The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity–mortality trials? (2007) (29)
- Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth (2014) (29)
- Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins. (1988) (29)
- Peroxynitrite Is a Key Mediator of the Cardioprotection Afforded by Ischemic Postconditioning In Vivo (2013) (28)
- Angiotensin-II mediates norepinephrine and neuropeptide-Y secretion in a human pheochromocytoma. (1994) (28)
- Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. (1981) (28)
- Review: Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension (2008) (27)
- Relationship Between the Prescriber's Instructions and Compliance with Antibiotherapy in Outpatients Treated for an Acute Infectious Disease (1997) (27)
- Triple-combination therapy in the treatment of hypertension: a review of the evidence (2017) (27)
- Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans. (1985) (27)
- Angiotensin II measurement with high‐affinity monoclonal antibodies (1988) (27)
- Blood Pressure Response to Central and /or Peripheral Inhibition of Phenylethanolamine N‐Methyltransferase in Normotensive and Hypertensive Rats (1981) (27)
- Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels. (1988) (26)
- Angiotensin-converting enzyme inhibitors in hypertension (1995) (26)
- Diabetes and Hypertension (2001) (26)
- Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis. (1985) (26)
- Renal Effects of Converting Enzyme Inhibition (1987) (26)
- Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures. (1988) (26)
- Pharmacokinetics of synthetic atrial natriuretic peptides in normal men (1987) (25)
- Reactive rise in blood pressure upon cuff inflation: cuff inflation at the arm causes a greater rise in pressure than at the wrist in hypertensive patients (2007) (25)
- Sepsis up-regulates the expression of connexin 40 in rat aortic endothelium* (2005) (25)
- Does pharmacological profiling of a new drug in normotensive volunteers provide a useful guideline to antihypertensive therapy? (1983) (25)
- Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. (1999) (25)
- Noninvasive Blood Pressure Monitoring at the Finger for Studying Short Lasting Pressor Responses in Man (1990) (24)
- Renin and the complications of acute myocardial infarction. (1984) (24)
- Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study. (2014) (24)
- The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. (1983) (24)
- Measurement of sympathetic nerve activity in the unanesthetized rat. (1989) (24)
- Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade. (1980) (24)
- Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture? (2001) (24)
- Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats. (1983) (24)
- In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells. (1991) (23)
- Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures. (1984) (23)
- Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue (1994) (23)
- Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment. (1987) (23)
- Neuropeptide Y normalizes renin secretion in adrenalectomized rats without changing blood pressure. (1986) (23)
- A review of irbesartan in antihypertensive therapy: comparison with other antihypertensive agents (2001) (23)
- Plasma angiotensin-(1-8) octapeptide measurement to assess acute angiotensin-converting enzyme inhibition with captopril administered parenterally to normal subjects. (1988) (23)
- Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y. (1987) (23)
- Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse. (2015) (22)
- Neuropeptide Y and cardiovascular regulation. (1993) (22)
- Prevention of Microalbuminuria in Patients With Type 2 Diabetes: What Do We Know? (2010) (22)
- Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE). (2011) (22)
- Target organ damage: how to detect it and how to treat it? (2009) (22)
- Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor. (1978) (21)
- Role of Reactive Hyperreninemia in Blood Pressure Changes Induced by Sodium Depletion in Patients with Refractory Hypertension (1981) (21)
- Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats. (1995) (21)
- Long-term clinical experience with enalapril in essential hypertension. (1983) (21)
- Clinical pharmacology of atrial natriuretic (3-28) eicosahexapeptide. (1986) (21)
- Major impact of body position on arterial stiffness indices derived from radial applanation tonometry in pregnant and nonpregnant women (2012) (21)
- Infusion of Atrial Natriuretic Peptide to Patients with Congestive Heart Failure (1988) (21)
- In-vitro response of plasma angiotensin converting enzyme to precursors and active forms of converting enzyme inhibitors (1984) (21)
- Atrial Natriuretic Peptide Administered as Intravenous Infusion or Bolus Injection to Patients with Liver Cirrhosis and Ascites (1988) (21)
- Effect of cold pressor test on the internal diameter of the radial artery. (1989) (21)
- Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats. (1982) (20)
- Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition. (1989) (20)
- Role of vasoconstrictor systems in experimental glucocorticoid-hypertension in rats. (1983) (20)
- Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy? (1999) (20)
- Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers (1991) (20)
- Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia. (1986) (19)
- Preserved Capillary Density of Dorsal Finger Skin in Treated Hypertensive Patients with or without Type 2 Diabetes (2012) (19)
- A guide for easy- and difficult-to-treat hypertension. (2014) (19)
- Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action. (1992) (19)
- Effect of sodium intake on gene expression and plasma levels of ANF in rats. (1988) (19)
- Fixed-Dose Combinations as Initial Therapy for Hypertension (2012) (19)
- Clinical pharmacology of ACE inhibition. (1989) (19)
- Self poisoning with enalapril. (1984) (19)
- Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats (1999) (18)
- Amlodipine and valsartan as components of a rational and effective fixed-dose combination (2009) (18)
- Hypertensive crisis treated with orally administered captopril (2004) (18)
- Profound impact of uncomplicated pregnancy on diastolic, but not systolic pulse contour of aortic pressure (2006) (18)
- Very-low-dose combination: a first-line choice for the treatment of hypertension? (2003) (18)
- Surrogate Markers for Atherosclerosis in Overweight Subjects With Atherogenic Dyslipidemia: The GEMS Project (2008) (18)
- Value of Different Clinical and Biochemical Correlates to Assess Angiotensin Converting Enzyme Inhibition (1994) (18)
- Trials in isolated systolic hypertension: An update (2003) (17)
- Efficacy and Safety of Various Combination Therapies Based on a Calcium Antagonist in Essential Hypertension: Results of a Placebo‐Controlled Randomized Trial (1993) (17)
- Once-daily lisinopril in hypertensive patients: effect on blood pressure and the renin-angiotensin system (1985) (17)
- Physiological response to whole-body vibration in athletes and sedentary subjects. (2014) (17)
- The ADVANCE Trial (2009) (17)
- Hypertension: which aspects of hypertension should we impact on and how? (2006) (17)
- Blood pressure recording in the ambulatory patient and evaluation of cardiovascular risk. (1985) (17)
- Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension. (1982) (17)
- Compliance with antihypertensive treatment: implications for practice. (1997) (16)
- Haemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation. (2009) (16)
- [Superficial pemphigus caused by captopril]. (1982) (16)
- Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats. (1987) (16)
- Functional late outgrowth endothelial progenitors isolated from peripheral blood of burned patients. (2013) (16)
- High level expression of human neuropeptide Y receptors in mammalian cells infected with a recombinant vaccinia virus (1993) (16)
- Compliance with medication among outpatients with uncontrolled hypertension in the Seychelles. (1995) (16)
- Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum? (2012) (16)
- Inhibitors of the renin-angiotensin system. (1993) (16)
- ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations? (2002) (16)
- Effect of angiotensin converting enzyme inhibition in renovascular hypertension. (1989) (15)
- Influence of Endogenous Bradykinin on Acute Blood Pressure Response to Vasopressors in Normotensive Rats Assessed with a Bradykinin Antagonist (1988) (15)
- Role of atrial natriuretic peptides and neuropeptide Y in blood pressure regulation. (1990) (15)
- Does renin determine the blood pressure response to calcium entry blockers? (1985) (14)
- Salt-induced hypertension in chronic renal failure: evidence for a neurogenic mechanism. (1983) (14)
- Neuropeptide Y Prevents the Blood Pressure Fall Induced by Endotoxin in Conscious Rats With Adrenal Medullectomy (1988) (14)
- Non‐invasive measurement of internal diameter of peripheral arteries during the cardiac cycle (1988) (14)
- Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man. (1987) (14)
- Blood Pressure Variability in Ambulatory Hypertensive Patients: Effect of β-Blocking Agents and/or Diuretics (1984) (14)
- INFLUENCE OF BRADYKININ ON BLOOD PRESSURE REGULATION OF SPONTANEOUSLY HYPERTENSIVE RATS MAINTAINED ON DIFFERENT SODIUM INTAKES (1987) (14)
- The hemodynamic response of conscious normotensive rats to atriopeptin III: Lack of a role of the parasympathetic nervous system. (1986) (14)
- Enhanced diastolic reflections on arterial pressure pulse during exercise recovery (2011) (14)
- Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system. (1988) (14)
- Accuracy, reproducibility and usefulness of ambulatory blood pressure recording obtained with the Remler system (1984) (14)
- INHIBITORY EFFECT OF NEUROPEPTIDE Y ON STIMULATED RENIN SECRETION OF AWAKE RATS (1992) (13)
- Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension. (1979) (13)
- Individualization of antihypertensive therapy. (1988) (13)
- Effect of Ganglion Blockade with Pentolinium on Circulating Neuropeptide Y Levels in Conscious Rats (1988) (13)
- Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers (2004) (13)
- Dose-response relationships of ACE inhibitors and angiotensin II blockers. (1994) (13)
- Influence of sodium intake on circulating levels of neuropeptide Y. (1987) (13)
- Interactions between NPY and its receptor: assessment using anti-NPY antibodies (1994) (13)
- Natriuretic Peptide Receptor B modulates the proliferation of the cardiac cells expressing the Stem Cell Antigen-1 (2017) (13)
- Use of oscillometric devices in atrial fibrillation: a comparison of three devices and invasive blood pressure measurement (2018) (13)
- Bilateral symmetry of radial pulse in high-level tennis players: implications for the validity of central aortic pulse wave analysis (2009) (13)
- What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition. (1988) (13)
- Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension. (2006) (12)
- Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy. (2013) (12)
- Critical review of cancer risk associated with angiotensin receptor blocker therapy (2011) (12)
- Angiotensin II antagonists. (1993) (12)
- [Angiotensin-converting-enzyme inhibition in arterial hypertension]. (1990) (12)
- Pharmacokinetics of angiotensin converting enzyme inhibitors. (1989) (12)
- Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension. (1981) (12)
- Clinical use of non-invasive ambulatory blood pressure recording. (1985) (12)
- Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors. (1989) (12)
- Evaluation of antihypertensive therapy: discrepancies between office and ambulatory recorded blood pressure. (1991) (12)
- Angiotensin antagonists. (1993) (12)
- Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective (2009) (12)
- Nighttime Blood Pressure: A Target for Therapy? (2010) (12)
- Blood-pressure reduction with LCZ696 (2010) (11)
- Calcium entry blockade attenuates the acute blood pressure rise induced by cigarette smoking. (1988) (11)
- [Nebivolol: a beta blocker with vasodilator properties]. (2000) (11)
- Clinical Studies with a Vascular Vasopressin Antagonist (1986) (11)
- Should Hypertensive Patients Take Vitamin D? (2012) (11)
- Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man. (1989) (11)
- Angiotensin II antagonists DuP 753 and TCV 116. (1994) (11)
- Haemodynamic role of vasopressin released during Finnish sauna. (1986) (11)
- Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist (1995) (11)
- SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers. (1997) (11)
- Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers. (1989) (11)
- Response of atrial natriuretic peptide to acute saline loading in essential hypertension. (1988) (11)
- No Major Impact of Skin Aging on the Response of Skin Blood Flow to a Submaximal Local Thermal Stimulus (2014) (11)
- Desensitization of Thermal Hyperemia in the Skin is Reproducible (2012) (11)
- A look through the new therapeutic window: irbesartan. (1998) (11)
- Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials (2006) (11)
- Response of plasma arginine vasopressin levels to rapid changes in altitude. (1984) (10)
- Elastic behaviour of the carotid artery in intact spontaneously hypertensive rats. (1993) (10)
- Renal haemodynamic and protective effects of calcium antagonists in hypertension. (1995) (10)
- Moderate hypercapnia exerts beneficial effects on splanchnic energy metabolism during endotoxemia (2009) (10)
- Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects. (1987) (10)
- Do We Need New Antihypertensive Drugs? (1996) (10)
- [What is behind masked hypertension?]. (2005) (10)
- Skin blood flow and cigarette smoking: the role of vasopressin. (1984) (10)
- Brachial or wrist blood pressure in obese patients: which is the best? (2008) (10)
- The management of the type 2 diabetic patient with hypertension – too late and too little: Suggested improvements (2008) (10)
- Control of vascular tone by renin and angiotensin in cardiovascular disease. (1993) (10)
- Achieving Blood Pressure Targets in the Management of Hypertension (2001) (9)
- Angiotensin converting enzyme inhibition and renin inhibition (1989) (9)
- Are surgery blood pressure measurements adequate to evaluate the efficacy of antihypertensive drugs? (1984) (9)
- Amlodipine/Valsartan Single-Pill Combination A Review of its Use in the Management of Hypertension (2009) (9)
- Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus. (2014) (9)
- Ambulatory blood pressure monitoring to assess cardiovascular risk in women. (2011) (9)
- Hypertension in a patient with hypercalcemia: captopril and verapamil. (1982) (9)
- Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats. (1994) (9)
- Angiotensin I and II disappear completely from circulating blood within 48 hours after binephrectomy: improved measurement of angiotensins in rat plasma. (1991) (9)
- What has been learned from electronic monitoring of compliance with antihypertensive medications? (2004) (9)
- What stands behind masked hypertension? (2008) (9)
- Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients. (1990) (9)
- Effect of metoclopramide on angiotensins, aldosterone, and atrial peptide during hypoxia. (1990) (9)
- Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers. (1996) (9)
- Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial (2007) (9)
- Rationale for the use of very-low-dose combinations as first-line treatment of hypertension. (2001) (9)
- Angiotensin converting enzyme inhibition and the normal kidney. (1987) (8)
- Antihypertensive effect of diltiazem administered once and twice daily. (1988) (8)
- Vasopressin dilates the rat carotid artery by stimulating V1 receptors. (1998) (8)
- Angiotensin-converting enzyme inhibition versus blockade of the renin-angiotensin system. (1989) (8)
- Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers. (1987) (8)
- Ambulatory blood pressure monitoring in children, adolescents and elderly people. (1991) (8)
- Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements? (2015) (8)
- Low-dose combinations versus monotherapies in the treatment of hypertension. (1997) (8)
- Experience with perindopril in normal volunteers. (1989) (8)
- The renin-angiotensin system and arterial wall behavior. (1993) (8)
- The problem of compliance with antihypertensive therapy. (2001) (8)
- Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography. (2011) (7)
- Pulse wave analysis of aortic pressure: diastole should also be considered (2013) (7)
- Fixed low-dose combination therapy for hypertension (2002) (7)
- Erratum: Hypertension: Which aspects of hypertension should we impact on and how? (Journal of Hypertension (2006) 24, SUPPL. 5 (S2-S5)) (2007) (7)
- Effect of mental stress on the tone of a medium‐sized muscular artery (1992) (7)
- Calcium Antagonists as First‐Line Therapy in Hypertension: Results of the Swiss Isradipine Study (1991) (7)
- Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats (1995) (7)
- Changes in treatment during and after hospitalization in patients taking drugs for cardiovascular diseases (1996) (7)
- Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension. (1987) (7)
- Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic. (1987) (7)
- Measurement with an automated oscillometric wrist device with position sensor leads to lower values than measurements obtained with an automated oscillometric arm device from the same manufacturer in elderly persons (2014) (7)
- Discordant prevalence of hypertension using two different automated blood pressure measurement devices: a population-based study in Dar es Salaam (Tanzania) (2004) (7)
- HEMODYNAMIC, RENAL, AND ENDOCRINE EFFECTS OF 4‐ H INFUSIONS OF HUMAN ATRIAL NATRIURETIC PEPTIDE IN NORMAL VOLUNTEERS (1988) (6)
- Position of fixed‐dose combinations containing an AT1‐receptor blocker and a thiazide diuretic (2005) (6)
- Hemodynamic Effects of a Kinin Antagonist (1990) (6)
- RATIONAL USE OF CAPTOPRIL (1979) (6)
- Effects of intranasal administration of synthetic (4-28)human atrial natriuretic peptide to normal volunteers. (1989) (6)
- Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome. (1989) (6)
- Responsiveness of renin secretion: a key mechanism in the maintenance of blood pressure. (1986) (6)
- Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade. (1987) (6)
- NPY Y1 receptor is not involved in the hemodynamic response to an acute cold pressor test in mice (2007) (6)
- Similarity of cutaneous reactive hyperemia in the forearm of women with and without hyperinsulinemia (2004) (6)
- A Review of the Clinical Experience with the Angiotensin II Receptor Antagonist Irbesartan (2006) (6)
- [Hypertension and vitamin D: not again]. (2011) (6)
- Neuropeptide Y: a missing link? (1990) (6)
- Eligibility to treatment and economic effect of the implementation of the new US or European Society of Hypertension/European Society of Cardiology hypertension guidelines (2015) (6)
- Chronic Treatment of Hypertensive Patients with Converting Enzyme Inhibitors (1986) (6)
- Ambulatory Blood Pressure Recording (1994) (6)
- Foot skin blood flow following infrainguinal revascularization for critical lower limb ischemia. (2006) (6)
- Ambulatory blood pressure monitoring in the elderly hypertensive patient. (1988) (6)
- Blood pressure and heart rate effect of a vasopressin antagonist in conscious normotensive rats pretreated with exogenous vasopressin. (1983) (6)
- Shortcomings of office blood pressures in assessing antihypertensive therapy. (1985) (5)
- Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: EXPERIENCE WITH ANGIOTENSIN II ANTAGONISTS IN HYPERTENSIVE PATIENTS (1996) (5)
- [Vasopressin in acute myocardial infarct: clinical implications]. (1986) (5)
- Vasopeptidase Inhibition: A New Approach to the Management of Cardiovascular Disease. (2000) (5)
- Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor. (1986) (5)
- [Practice guidelines of the European Society of Hypertension for home blood pressure measurement]. (2010) (5)
- Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders (2004) (5)
- Effects of atrial natriuretic peptide in man (1987) (5)
- The clinical application of converting enzyme inhibitors. (1983) (5)
- Experience with angiotensin II antagonists in hypertensive patients. (1996) (5)
- Atrial natriuretic peptide and urinary prostaglandins in man. (1989) (5)
- Ambulatory blood pressure monitoring in adolescent untreated hypertensive patients. (1986) (5)
- Clinical applications of antimineralocorticoids. (1988) (5)
- Impact of body tilt on the central aortic pressure pulse (2015) (5)
- Hypotensive effect of human factor XII active fragment in conscious normotensive rats: role of bradykinin. (1984) (5)
- Medical treatment of hypertension in Switzerland (5)
- Identification and quantitation of angiotensins. (1986) (5)
- Combined treatment with captopril, hydrochlorothiazide and pravastatin in dyslipidemic hypertensive patients. (1995) (5)
- Ambulatory blood pressure measurement and antihypertensive therapy. (1989) (5)
- Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats. (1996) (5)
- [Angioedema during ACE and DPP-4 inhibition]. (2010) (5)
- Treatment of Hypertension with ACE Inhibitors as First Step: Pharmacologic and Clinical Considerations (1987) (5)
- Masked hypertension : a systematic review. Commentary (2008) (5)
- The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers (1985) (5)
- Pharmacology of converting enzyme inhibitors. (1987) (4)
- [Arterial hypertension. Factors favoring long-term compliance with therapy]. (2007) (4)
- Salt Subtraction in Patients on Maintenance Hemodialysis (1985) (4)
- Clinical Utility of Ambulatory Blood Pressure Monitoring in the Evaluation of Patients with Borderline Hypertension (1994) (4)
- Blood pressure monitoring for quality assessment of antihypertensive therapy. (1986) (4)
- Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A (2004) (4)
- Ambulatory blood pressure monitoring: a mean to stratify cardiovascular risk (2007) (4)
- Role of endogenous bradykinin in blood pressure control of conscious rats. (1988) (4)
- ANGIOTENSIN II ANTAGONISTS: A NEW CLASS OF ANTIHYPERTENSIVE AGENT (1996) (4)
- Diagnosis and treatment of resistant hypertension (2014) (4)
- The hemodynamics of septic shock: a historical perspective. (2013) (4)
- Various approaches to blockade of the renin-angiotensin system: persistent renin response. (1990) (4)
- Pharmacodynamic and humoral effects of single intravenous doses of captopril in normal subjects. (1987) (4)
- Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients. (1990) (4)
- A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers (2004) (4)
- No Implication of Thromboxane Prostanoid Receptors in Reactive Hyperemia of Skin and Skeletal Muscle in Human Forearm (2013) (4)
- Blockade of the vascular effect of vasopressin in patients with mild essential hypertension. (1986) (4)
- Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients. (1979) (4)
- Octapeptide-specific and sensitive assay for angiotensin II in plasma. (1986) (4)
- AT1receptor antagonism in hypertension: what has been learned with irbesartan? (2003) (4)
- Nebivolol and valsartan: useful treatment for hypertension? (2014) (4)
- Blockade of the renin‐angiotensin system in humans: converting enzyme inhibitors, rennin inhibitors, and angiotensin II antagonists (1991) (4)
- Effect of Neuropeptide Y on Stimulated Renin Secretion a (1990) (3)
- Effect of Centrally Acting Antihypertensive Drugs on the Renin‐Angiotensin System and Vasopressin (1984) (3)
- Cardiovascular effects of fentanyl in conscious rats (2001) (3)
- [Acute renal insufficiency following inhibition of the angiotensin conversion enzyme by various agents]. (1984) (3)
- Calcium deficiency in the elderly: a factor contributing to the development of hypertension. (1994) (3)
- [Whole-body vibration training: fact or fiction?]. (2008) (3)
- Strategies for the management of hypertension in aircrew. (1992) (3)
- The Renin System in Hypertension (1987) (3)
- Enhanced Acute Antihypertensive Effect of Propranolol in the Absence of Circulating Epinephrine in the Rat (1984) (3)
- [ADVANCE: a morbidity mortality study of diabetes and hypertension]. (2008) (3)
- EFFICACY AND TOLERANCE OF ISRADIPINE AND SUSTAINED-RELEASE NIFEDIPINE IN THE MANAGEMENT OF HYPERTENSION (1991) (3)
- Effect of indomethacin and propranolol on the blood pressure and renin response to atriopeptin III in conscious rats (1987) (3)
- The Place of Microelectronic Systems in Measuring Compliance (2002) (3)
- Pre- and Postsynaptic Effects of SKF64139, a Phenylethanolamine N‐Methyltransferase Inhibitor, in Conscious Normotensive Rats (1982) (3)
- Arterial compliance and distensibility in spontaneously hypertensive rats (1992) (3)
- Ambulatory blood pressure monitoring as a means to avoid overtreatment of elderly hypertensive patients. (1992) (3)
- Fixed-dose combination therapy with calcium antagonists. (2002) (3)
- Potential Cardioprotective Effect of Mibefradil in the Long-Term Treatment of Hypertension (1998) (3)
- Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition. (1988) (3)
- [Role of bradykinin in hypotension induced by the active factor derived from factor XII]. (1984) (3)
- Regulation of renin secretion in conscious adrenalectomized rats with glucocorticoid-induced hypertension. (1986) (3)
- Cardiac mass in glucocorticoid-hypertensive rats with and without circulating adrenaline. (1985) (2)
- Do optimal antihypertensive drug regimens allow blood pressure normalization in all patients with resistant hypertension? (2013) (2)
- [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?]. (1988) (2)
- Initial evaluation of the angiotensin converting enzyme inhibitor CGS 13945 in hypertensive patients (1985) (2)
- Le traitement de l'HTA : une simple routine ? (2002) (2)
- [Arterial hypertension: macrocirculation and microcirculation]. (2009) (2)
- Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians. (1985) (2)
- Salt subtraction in patients on maintenance hemodialysis. Efficacy and limitations. (1985) (2)
- [The revived interest in aldosterone antagonists]. (2006) (2)
- What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension? (2005) (2)
- [Medicine and adolescent health; why this new discipline, for whom and how?]. (2000) (2)
- Circulating and tissue renin-angiotensin system: present and future. (1989) (2)
- Position Paper: Angiotensin-Converting Enzyme Blockade as a Therapeutic Modality (1981) (2)
- Clinical Application of Treatment with Angiotensin Receptor Antagonists (1994) (2)
- Captopril: an oral angiotension converting enzyme inhibitor active in man. (1980) (2)
- Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension (2008) (2)
- Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists (1994) (2)
- Differential persistence with initial antihypertensive therapies: a clue for understanding the needs of hypertensive patients. (2006) (2)
- [Non invasive measurement of arterial compliance]. (1991) (2)
- [Angiotensin II receptor blockers (ARBs) and cancer: a reassuring balance]. (2011) (2)
- [Stratification of global cardiovascular risk according to the ESH/ESC guidelines]. (2007) (2)
- [Physiopathology of left ventricular hypertrophy]. (1995) (2)
- Oxidative stress: A pivotal link among cardiovascular risk factors? (2005) (2)
- BLOOD PRESSURE CONTROL IN EUROPE (2008) (2)
- [Changes in medications acting on the cardiovascular system during hospitalization]. (2000) (2)
- [Antihypertensive therapy according to the ESH/ESC guidelines]. (2007) (2)
- First‐line pharmacological treatment of hypertension (1992) (2)
- MECHANISMS OF THE PRESSOR RESPONSE TO INTRAVENOUS THYROTROPIN‐RELEASING HORMONE IN THE RAT (1994) (2)
- [Evaluation using a logbook of mastering of clinical skills by medical students]. (2010) (2)
- Effects of Synthetic Atrial Natriuretic Peptides on Regional Blood Flow in Normal Volunteers (1986) (2)
- [Effect of atrial natriuretic factor on the hematocrit of patients in chronic hemodialysis]. (1987) (2)
- [Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination]. (1992) (2)
- [Role of vasopressin in reducing the cutaneous blood flow induced by cigarette smoke]. (1984) (2)
- [The treatment of arterial hypertension: is it a simple routine?]. (2002) (2)
- [Potentiation of the antihypertensive effect of captopril by diuretics (author's transl)]. (1979) (2)
- Endocrine Response to Heart Failure (1988) (1)
- 0232: A new role of the brain natriuretic peptide in the heart: Modulation of cardiac precursor cell proliferation and differentiation (2014) (1)
- Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness. (1990) (1)
- Enhanced renin secretion in adrenalectomized rats with glucocorticoid-induced hypertension. (1985) (1)
- Renin secretion: the difficulty of extrapolating from in vitro to in vivo studies. (1995) (1)
- [Hypertension: early detection of target organ damage]. (2007) (1)
- [Hypertension. Effects of antihypertensive therapy on cognitive functions]. (2013) (1)
- Alpha 1-adrenoceptor blockade in renal hypertensive rats with low and high renin levels. (1984) (1)
- Differential blood pressure response to atriopeptin III and sodium nitroprusside in conscious rats with adrenal medullectomy. (1987) (1)
- Implications cliniques de la pression centrale (2006) (1)
- [Treatment of hypertensive crisis with captopril]. (1983) (1)
- Endotoxin-induced hypotension in rats is not mediated by prekallikrein activation. (1987) (1)
- Plasma renin levels: the lower the better in terms of cardiovascular risk? (2012) (1)
- Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril (1984) (1)
- Atrial natriuretic peptides: Reproducibility of renal effects and response of liver blood flow (2004) (1)
- Hematocrit Is Increased by Atrial Natriuretic Peptide in Nephrectomized Rats (1986) (1)
- Circulating and tissular renin-angiotensin systems. (1989) (1)
- Renal Site of the Effect of Atrial Natriuretic Peptide in Normal Volunteers (1986) (1)
- [Vasopeptidase inhibition: a new mechanism of action--a new antihypertensive drug]. (2000) (1)
- Lack of a Role of the Parasympathetic Nervous System in the Haemodynamic Response of Normotensive Rats to Atriopeptin III (1986) (1)
- Postpropranolol vasodilation in adrenalectomized glucocorticoid hypertensive rats. (1987) (1)
- [New recommendations of the ESH/ESC: smooth changes for the hypertensive patient]. (2013) (1)
- [Orthostatic hypotension: what to think of it and what to do?]. (2013) (1)
- Invited review Blood pressure control based on office and ambulatory blood pressure monitoring: the European experience in hypertensive patients treated in clinical practice (2009) (1)
- Effect of prolonged angiotensin converting enzyme inhibition on ambulatory blood pressure of normotensive volunteers. (1987) (1)
- [Understanding Raynaud's phenomenon: towards a better treatment]. (2006) (1)
- [Extrarenal effects of the atrial natriuretic factor]. (1987) (1)
- Comparative study of three parenteral inhibitors of the angiotensin converting enzyme. (1981) (1)
- [Therapeutic strategy in arterial hypertension]. (1987) (1)
- Plasma Angiotensin I Determines the Rate of Angiotensin II Generation Even during ACE Inhibition (1988) (1)
- 108. Drug concentration-response relationships in normal volunteers after oral administration of DuP 753, an angiotensin II antagonist (1991) (1)
- Neither hydralazine nor captopril significantly shifts carotid artery distensibility-pressure curves determined in intact spontaneously hypertensive rats. (1991) (1)
- Antihypertensive efficacy of cilazapril in general practice: assessment by ambulatory blood pressure monitoring. (1993) (1)
- [How urgent is it to decrease high blood pressure?]. (2008) (1)
- 235 Influence of sodium intake on the renin-angiotensin system of rats with hypertension caused by chronic inhibition of nitric oxide synthesis (1993) (1)
- Alterations in cardiac hemodynamics following endotoxin are not due to reduced myocardial contractility (2008) (1)
- Atrial Natriuretic Peptide Raise Hematocrit in Conscious Nephrectomized Rats (1987) (1)
- [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme]. (1978) (1)
- 3. Effects of neuropeptide Y on renal hemodynamics and plasma renin activity of conscious normotensive rats (1991) (1)
- Leuven consensus conference on ambulatory BP monitoring task force IV: self-monitoring of the blood pressure (2000) (1)
- [Diagnosis and treatment of hypertensive emergencies]. (1995) (1)
- [Clinical implications of central blood pressure]. (2006) (1)
- Antihypertensive Agents: Mechanisms of Drug Action (2003) (1)
- Influence of sodium balance on atrial natriuretic factor in rats with one-kidney, one-clip renal hypertension (1990) (1)
- Implementation of an Integrated Educational Curriculum at the Medical Faculty of Lausanne (1997) (1)
- The Position of β-Blockers in Antihypertensive Therapy (1979) (1)
- [Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude]. (2012) (1)
- Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers (2004) (1)
- [OP.1A.01] REPRODUCIBILITY AND ACCURACY OF BLOOD PRESSURE MEASUREMENTS WITH THREE OSCILLOMETRIC DEVICES IN PATIENTS WITH ATRIAL FIBRILLATION (2016) (1)
- BETTER EFFICACY IN HYPERTENSION MANAGEMENT WITH PERINDOPRIL/INDAPAMIDE (PER/IND) STRATEGY COMPARED TO SEQUENTIAL OR STEP BY STEP STRATEGIES. STRATHE STUDY: STRATEGIES OF TREATMENT IN HYPERTENSION (2004) (1)
- Characterization and Use of Four Anti‐NPY Monoclonal Antibodies to Study NPY‐Receptor Interaction (1990) (1)
- The place of ACE inhibition in the modern therapeutic era: beyond blood pressure control. Introduction. (1998) (1)
- PP125. High mobility group box 1 protein (HMGB1): A pathogenic role in preeclampsia? (2012) (1)
- [Effect of synthetic atrial natriuretic factors on various regional blood flows in the healthy subject]. (1986) (1)
- Effects of dextronatrin on blood pressure, hematocrit, urinary sodium excretion and sympathetic nerve activity of rats (1990) (1)
- [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol]. (1983) (1)
- [Muscle enzyme activity and exercise]. (2009) (1)
- [Non-invasive central blood pressure measurement: how and why?]. (2007) (0)
- PROTECTION BY α1-ANTITRYPSIN ALA-357 ARG-358 AGAINST ARTERIAL HYPOTENSION INDUCED BY FACTOR XII FRAGMENT (1987) (0)
- A lifelong effort to improve the methodology for measuring blood pressure. (2010) (0)
- [Normalization of arterial pressure in all hypertensive patients: mission impossible?]. (1998) (0)
- T-channel blockade: A new advance in the treatment of cardiovascular diseases, F. Hoffman-La Roche Satellite Symposium to the ESC Congress, Stockholm, August 24, 1997: Introduction (1998) (0)
- Combination of valsartan with hydrochlorothiazide, amlodipine or both: for whom and when? (2011) (0)
- [Role of atrial natriuretic peptide in the renal response to acute volume expansion in the normal and essential hypertensive patient]. (1988) (0)
- [Renal function after administration of angiotensin-converting enzyme inhibitors]. (1987) (0)
- Role of Neuropeptide y in Endotoxemia (2019) (0)
- [Angiotensin II antagonists and cancer: a storm that can do good ]. (2010) (0)
- P-210: Beta-blockade with nebivolol enhances the acetylcholine-induced vasodilation in the cutaneaous vascular bed of normotensive volunteers (2001) (0)
- [Individualization of the antihypertensive treatment]. (1989) (0)
- Blockers of the renin–angiotensin–aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases! (2012) (0)
- [The ACCOMPLISH trial: are results really unexpected?]. (2009) (0)
- Thoracic fat volume is independently associated with coronary vasomotion (2016) (0)
- [Atrial natriuretic factor in man: physiopathological implications]. (1988) (0)
- [Hypertension: new European guidelines have arrived! BP <140/90 mmHg for all]. (2013) (0)
- [Clinical experiences with atrial natriuretic factor]. (1987) (0)
- [Usefulness of the Remler device in avoiding overtreatment of the so-called hypertensive population]. (1983) (0)
- [Angiotensin II antagonists: a distinct therapeutic class]. (1996) (0)
- Impact of depression on drug intake in hypertensive patients. (2010) (0)
- Whole-Body Vibration Training Elevates Creatine-Kinase Levels in Sedentary Subjects: 1420 (2010) (0)
- [Arterial Hypertension: turning a new leaf!]. (2012) (0)
- Reduction of Skin Blood Flow by Cigarette Smoking: The Role of Vasopressin (1985) (0)
- [Again and again...new recommendations for the management of hypertension]. (2007) (0)
- 179 Active dilation of the carotid artery induced by vasopressin in the intact rat (1993) (0)
- [Normalization of renin secretion by neuropeptide Y in adrenalectomized rats with glucocorticoid-induced hypertension]. (1986) (0)
- Hypertension résistante au traitement. (2003) (0)
- Twenty-four hour blood pressure monitoring: in ambulatory conditions or in-hospital? (2006) (0)
- Blood Pressure Response to Central and/or Peripheral Inhibition of Phenylethanolamine iV-Methyltransferase in Normotensive and Hypertensive Rats (2005) (0)
- Compliance withmedication amongoutpatients withuncontrolled hypertension inthe (1995) (0)
- Mediators in Septic Shock: The Renin-Angiotensin System (2019) (0)
- Highlights from International Congress (2008) (0)
- [Physical exercise and arterial hypertension]. (1988) (0)
- [Arterial hypertension: details concerning the "update" emission]. (2006) (0)
- [Preliminary evaluation of the Profilomat, a new portable blood pressure recorder]. (1992) (0)
- 0006 : Proliferation of the cardiac precursor cells expressing the stem cell antigen-1 is controlled by activation of the natriuretic peptide receptors (2016) (0)
- [Blood pressure recording in outpatient service: experience with the Sandoz Pressure System]. (1993) (0)
- [CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. (2021) (0)
- [Are all diuretics equal for the treatment of hypertensive patients?]. (2012) (0)
- Long-term follow-up study of hypertensive patients by practicing internists after a controlled drug trial. (1984) (0)
- Author Index/Subject Index (2019) (0)
- [CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. (2021) (0)
- [7th symposium d'Ouchy: "How to and use appropriate medical measures for managing low back pain in general practice?"]. (2001) (0)
- PEROXYNITRITE TRIGGERS MYOCARDIAL CASPASE-3 ACTIVATION AND POLY(ADP-RIBOSE) POLYMERASE CLEAVAGE IN VITRO AND IN VIVO.: 189-S (2005) (0)
- [Ambulatory blood pressure monitoring: essential for diagnosing and treating hypertension?]. (2014) (0)
- [Usefulness of ambulatory blood pressure monitoring in hypertensive patients]. (1986) (0)
- [Usefulness of ambulatory registration of arterial pressure in therapeutic trials of antihypertensive agents]. (1985) (0)
- T-channel blockade : a new advance in the treatment of cardiovascular diseases : F. Hoffman-La Roche satelite symposium to the ESC congress, Stockholm, August 24, 1997 (1993) (0)
- The need for hospitalization still represents a major burden for hypertensive patients and healthcare systems. (2013) (0)
- Large Variations in Pulse Wave Velocity and Reflection Patterns occur during a Hemodialysis Session and are not Related to the Degree of Ultrafiltration (2018) (0)
- Clinical application of orally active angiotensin converting enzyme inhibitors. (1983) (0)
- P619Role of Toll-like receptor 5 in the development of post-myocardial infarction inflammation (2014) (0)
- Reduced Contribution of Wave Reflection to Peak Systolic Aortic Pressure in the Course of Recovery from Acute Exercise: 2081 (2006) (0)
- Effect of human atrial natriuretic factor on renal plasma flow. (1987) (0)
- [Attenuation of the vasopressor effect of angiotensin II, vasopressin and alpha 1-adrenergic stimulation by bradykinin]. (1987) (0)
- [Ambulatory blood pressure monitoring in the assessment of the hypertensive patient]. (1996) (0)
- Position of Diuretics in the Management of Hypertension (2007) (0)
- [Measurement of blood pressure: best way to assess cardiovascular risk?]. (1997) (0)
- [Fixed antihypertensive drug combinations]. (1999) (0)
- [Heart diseases]. (2011) (0)
- [Drug industry influence on hypertension treatment trials]. (2005) (0)
- Pericardial fat volume correlates with coronary vasomotion (2011) (0)
- Stroke syndromes: Muscle, peripheral nerve and autonomic changes (2001) (0)
- 47 The value of different humoral correlates in assessing the blockade of angiotensin II generation by the angiotensin converting enzyme inhibitor CS 622 (1993) (0)
- Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension. (1981) (0)
- Assessment of coronary vasoreactivity by MDCT: A validation study with 82Rb cardiac PET/CT (2010) (0)
- CLINICAL AND EXPERIMENTAL ASPECTS OF THE ANGIOTENSIN CONVERTING ENZYME IN BLOOD PRESSURE REGULATION (1983) (0)
- Use of the Terumo SP Catheter System for Crossing the Pulmonary Valve in Infants With Critical Pulmonary Valve Stenosis (1995) (0)
- [Effects of perfusion of human atrial natriuretic factor in normal volunteers]. (1986) (0)
- [Hypertension in pregnancy]. (2009) (0)
- [Abdominal pain and hypertension]. (1987) (0)
- Consensus Document European Society of Hypertension practice guidelines for ambulatory blood pressuremonitoring (2014) (0)
- [Evidence-based medicine in routine clinical practice]. (2000) (0)
- [Treatment of patients at high cardiovascular risk: confirmation and surprising results of the ONTARGET-Study]. (2008) (0)
- [Angiotensin II antagonists and cancer: the straw fire is extinguished]. (2011) (0)
- [Sudden death in young athletes]. (2007) (0)
- Can the development of severe hypertension be predicted? (2014) (0)
- [Diagnostic assessment of hypertensive patients]. (1989) (0)
- [Usefulness of BNP measurement for stratifying cardiovascular risk in hypertensive patients]. (2011) (0)
- The renin system in hypertension. A review. (1987) (0)
- ISVH Society September Newsletter (2007) (0)
- [Emergency and hypertensive crisis: definition and treatment]. (1995) (0)
- [Non-invasive methods of evaluation in hypertensive patients]. (1987) (0)
- [Recent updates for high risk cardiovascular patient and "very" recent updates for the "very" elderly]. (2008) (0)
- Rational Prescribing in Suboptimal Compliance (2002) (0)
- Experience with perindopril in normal volunteers. (1989) (0)
- [Absence of a role for the parasympathetic nervous system in the hemodynamic response to atriopeptin III in the normotensive rat]. (1986) (0)
- Trials in isolated systolic hypertension: An update (2003) (0)
- Axon reflex–mediated vasodilation is reduced in proportion to disease severity in TTR-FAP (2018) (0)
- Bacterial flagellin triggers myocardial innate immune responses and acute contractile failure (2008) (0)
- [Treating arterial hypertension: do not lower your attention!]. (2008) (0)
- Therapy of hypertension (2005) (0)
- [Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons]. (1986) (0)
- 27 Cross-talk between intracellular calcium signalling pathways activated by neuropeptide Y and angiotensin II in human erythroleukaemia cells (1993) (0)
- Antihypertensive therapy and mobilization of renal functional reserve. (1991) (0)
- [Physical exercise and arterial hypertension]. (1989) (0)
- Pass the salt (2005) (0)
- Guideline European Society of Hypertension Position Paper on Ambulatory Blood PressureMonitoring (2013) (0)
- 0129 : Adult human mononuclear clones isolated from peripheral blood can differentiate into immature cardiomyocytes (2015) (0)
- BLOOD PRESSURE CONTROL IN UNCOMPLICATED AND COMPLICATED HYPERTENSION IN SWITZERLAND: PP.1.24 (2011) (0)
- Current guidelines for drugs blocking the renin–angiotensin system (2012) (0)
- Reciprocal changes in vasoactive hormones in the rat myocardial infarction model of heart failure. (1994) (0)
- The use of angiotensin II antagonists in combination treatment of hypertension (2006) (0)
- Pharmacokinetics ofangiotensin converting enzymeinhibitors (1989) (0)
- [What have we learned about inhibitors of the renin-angiotensin system?]. (1986) (0)
- [Hypertension and medication compliance: a challenge every day]. (2014) (0)
- The Role of Irbesartan in Hypertension and Diabetic Kidney Disease (1999) (0)
- The flagellin/Toll-like receptor 5 axis elicits diffuse proinflammatory signaling and innate immune defenses in vivo (2008) (0)
- Blood pressure control: a review on irbesartan (2000) (0)
- [New therapeutic approaches to arterial hypertension]. (1982) (0)
- CURRENT ANTIHYPERTENSIVE THERAPY IN SWITZERLAND: PP.1.25 (2011) (0)
- P87. Peroxynitrite exerts complex and opposite effects on nuclear factor kappa B: A novel redox-based mechanism controlling cell signal transduction (2008) (0)
- [Comparison of therapeutic strategies in the management of hypertension]. (2005) (0)
- Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril. (1986) (0)
- [Need of antihypertensive therapy in patients aged 80 years or more]. (2008) (0)
- P1873Incidence rates of oedema with triple therapy amlodipine/valsartan/HCTZ as compared to valsartan/amlodipine and valsartan/HCTZ dual combination therapy (2018) (0)
- [The importance of therapy compliance in the treatment of arterial hypertension]. (1993) (0)
- [Changes of altitude in cable cars. Cardiovascular effects on healthy subjects]. (1984) (0)
- EVALUATION DE MARQUEURS P ARACLINIQUES DE L'ATHEROSCLEROSE CHEZ DES SUJETS SOUFFRANT D'UN EXCES PONDERAL ET D'UNE DYSLIPIDEMIE. «Surrogate Markers for Atherosclerosis in Overweight Subjects With Atherogenic Dyslipidemia: The GEMS Project (peer-reviewed)» Angiology 2008 Aug-Sep;59(4):484-92 (2014) (0)
- [Treatment strategies in essential arterial hypertension]. (1999) (0)
- A community-based intervention program to effectively treat hypertension in developing countries. (2013) (0)
- [Masked hypertension. Where to look?]. (2016) (0)
- A PATIENT WITH HYPERTENSION UNCONTROLLED BY PREVIOUS TREATMENT: S3.2 (2010) (0)
- [Cardiac insufficiency: how can we treat it?]. (1991) (0)
- VASOPEPTIDASE-INHIBITOR OMAPATRILAT (1999) (0)
- British Medical Journal (1868) (0)
- L'hypertension réfractaire : Hypertension (2001) (0)
- 0130 : Is the stem cell antigen 1 involved in the brain natriuretic peptide effect on cardiac precursor cells? (2015) (0)
- [Practical consequences blood pressure variability]. (1992) (0)
- THE DIASTOLIC PART OF THE CENTRAL AORTIC PRESSURE WAVEFORM SHOULD NOT BE NEGLECTED IN PULSE WAVE ANALYSIS: PP.41.316 (2011) (0)
- [ACE inhibitors and their clinical significance]. (1987) (0)
- POSITION OF FIRST-LINE COMBINATION THERAPY AMONG ANTIHYPERTENSIVE STRATEGIES: RESULTS OF THE STRATHE TRIAL (2004) (0)
- [CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. (2021) (0)
- Effect of ANF on Urinary Kallikrein in Normal Man (1986) (0)
- [Effects of clonidine on tourniquet-induced systemic arterial hypertension in general anesthesia]. (1989) (0)
- Ambulatory blood pressure monitoring to assess antihypertensive therapy in private practice. (1993) (0)
- [Hypertension. Arterial pressure in the acute phase of cerebrovascular accidents]. (2005) (0)
- PRESERVED CAPILLARY DENSITY IN TREATED HYPERTENSIVE PATIENTS WITH OR WITHOUT TYPE 2 DIABETES: 7E.04 (2011) (0)
- [CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. (2021) (0)
- Atrial Natriuretic Peptide ANP and Plasma Digitalis-Like Activity (1986) (0)
- [Antihypertensive agents used as first line agents: beta-blockers under pressure]. (2006) (0)
- [The goal in treating arterial hypertension]. (1999) (0)
- Mild Hypertension: To Treat or Not to Treat? (2013) (0)
- The hypertension optimal study (1998) (0)
- Effects of aortic valve replacement on blood pressure, neurohumoral regulation, and arrhythmias in patients with aortic stenosis. (1987) (0)
- STUDY PROTOCOL AND DEMOGRAPHICS IN TYPE II DIABETICS WITH HYPERTENSION * AND / OR HYPERALBUMINURIAt Study (0)
- Medical Therapy in Renovascular Hypertension: Angiotensin-Converting Enzyme Inhibitors (1992) (0)
- 0128 : Sca-1 positive cells, but not c-kit positive cells, differentiate into mature cardiomyocytes after brain natriuretic peptide treatment (2015) (0)
- [Wegener's granulomatosis: current concepts]. (1978) (0)
- 1.P.211 Patterns of non compliance to cholesterol-lowering therapy assessed by electronic monitoring (1997) (0)
- La codification des références citées ciaprès est extraite de la Classification Alpha Numérique de Documentation médicale et pharmaceutique (CANDO) (2008) (0)
- [Antihypertensive therapy: who should be treated and to which target?]. (2006) (0)
- [Diagnosis and treatment of arterial hypertension in the elderly]. (1996) (0)
- [Intrauniversitary selection: a good or a bad way to identify the best medical students?]. (2004) (0)
- Correction: Peroxynitrite Is a Key Mediator of the Cardioprotection Afforded by Ischemic Postconditioning In Vivo (2013) (0)
- [Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment]. (2003) (0)
- [New data on experimental endotoxic shock]. (1987) (0)
- [What have we learned from converting enzyme inhibitors on renin-angiotensin system?]. (1992) (0)
- [ACE inhibitors in the treatment of hypertension in elderly patients]. (1991) (0)
- T-Channel Blockade: A New Advance in the Treatment of Cardiovascular Diseases Satellite Symposium to the ESC Congress, Stockholm, August 1997 (1998) (0)
- 21 Biotinylation and fluorescein labelling of angiotensin II (1991) (0)
- Human angiotensin I competes with two non‐thiol converting enzyme inhibitors (CGS 13934 & MK‐422) to inhibit the angiotensin‐converting enzyme activity of human plasma (1984) (0)
- [Use of ambulatory recording of arterial pressure]. (1983) (0)
- The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents. (1979) (0)
- Subject Index, Vol. 47, 1987 (1987) (0)
- Axon reflex-mediated vasodilation is reduced in proportion to disease severity in familial amyloid polyneuropathy (2015) (0)
- Ambulatory blood pressure recordings. Reproducibility and unpredictability. (1984) (0)
- [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?]. (1992) (0)
- MEDICAL TREATMENT OF HYPERTENSION: MONOTHERAPY AND COMBINATION THERAPY (2014) (0)
- Vibration Training Elicits a Mixed Aerobic and Resistance-type Exercise in Sedentary Subjects: 681 (2010) (0)
- [A new strategy in the treatment of hypertension and its lesions on the target organs]. (2004) (0)
- [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension]. (2012) (0)
- [Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure]. (1985) (0)
- Antihypertensive agents in fixed combination (1999) (0)
- [Atherosclerotic renal stenosis: indications for revascularisation]. (2008) (0)
- [Hypertension 2009: what's new?]. (2009) (0)
- Efficacy of Antihypertensive Monotherapies Assessed by Ambulatory Blood Pressure Monitoring: Is There Really a Winner? (2015) (0)
- 12 - Diagnosis of Small-fiber neuropathy using the quantitative evaluation of axon reflex-mediated vasodilation (2015) (0)
- Comparative Cardiovascular Effects of Drugs Used for Hypertension (2012) (0)
- [Profiles and variations of ambulatory arterial pressure in treated and untreated hypertensive patients]. (1983) (0)
- [Initial results of the HOT-study in Switzerland (hypertension optimal treatment)]. (1995) (0)
- 46 Inhibition of pressor responses to exogenous angiotensin II during an 8-day oral treatment of normal subjects with TCV116, an angiotensin II antagonist (1993) (0)
- challengeventriculoarterial responses to orthostatic Carotid artery pulse wave time characteristics to (2015) (0)
- [New recommendations for the treatment of the hypertensive patient: a theoretical concept or a useful tool in practice?]. (2000) (0)
- [Reduction of skin blood flow by cigarette smoke: role of vasopressin]. (1985) (0)
- Non-invasive ambulatory blood pressure recording (1990) (0)
- P90Necrotic cardiomyocytes release soluble pro-inflammatory molecule(s) inducing il1r/myd88-dependent inflammatory responses in cardiac fibroblasts (2014) (0)
- Traitement chronique de l'hypertension arterielle par un inhibiteur de l'enzyme de conversion de l'angiotensine. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme] (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bernard Waeber?
Bernard Waeber is affiliated with the following schools:
